Ecolab Closes Sale Of Global Surgical Solutions Business For ~$950M In Cash, Announces Intent To Repurchase Up To $500M Of Its Stock
Ecolab Closes Sale Of Global Surgical Solutions Business For ~$950M In Cash, Announces Intent To Repurchase Up To $500M Of Its Stock
藝康集團以約9,500萬美元現金完成全球手術解決方案業務出售，並宣佈意圖回購高達5,000萬美元的股票。
Announces Intent to Repurchase up to $500 Million of Its Stock
宣佈擬回購價值最多5000萬美元的股票
Ecolab Inc. today closed on the sale of its global surgical solutions business to Medline for total consideration of approximately $950 million in cash. With Ecolab's strong balance sheet, the proceeds from this transaction enhance the company's ability to invest in attractive growth opportunities and return capital to shareholders. Therefore, the company announced its intent to repurchase up to an additional $500 million of Ecolab stock during the second half of 2024.
藝康集團今天完成了其全球手術解決方案業務向Medline的出售，總價值約爲9.5億美元現金。憑藉藝康集團的強勁資產負債表，此次交易收益可以增強該公司在有吸引力的增長機會上的投資能力並回報股東。因此，該公司宣佈計劃在2024年下半年再回購多達5000萬美元的藝康集團股票。